A specialist in life sciences and technology, Bristows LLP is well-equipped to deliver ‘pragmatic, risk-based advice’ to global pharma, biotech and medical device companies on regulatory matters and licensing, collaboration, and M&A transactions. Its dedicated IP litigation team is recognised for leveraging scientific knowledge to ’tactical advantage’ in precedent-setting cases before UK and European courts. The ‘dedicated’ team is led by experienced patent litigator Liz Cohen and Richard Dickinson, who focuses on commercial transactions and IP advisory. Brian Cordery and Robert Burrows are renowned for their patent litigation experience, while Adrian Chew handles patent enforcement and validity matters. Alex Denoon is ’extremely knowledgeable’ in regulatory matters, especially concerning disruptive technologies, while Xisca Borrás specialises in EU and UK life sciences law. The ‘outstanding’ Claire Smith advises on a range of life sciences transactions alongside Matthew Warren. Competition expert Robert Vidal arrived from Pinsent Masons LLP in January 2025. Gemma Barrett is no longer at the firm.
Legal 500 redaktioneller Kommentar
Anwält*innen
Leading partners
Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.
Next Generation Partners
Juniorpartner*innen, die im Markt von Mandanten und Wettbewerbern anerkannt werden und in einigen Mandaten eine Schlüsselrolle einnehmen.
Praxisleitung
Liz Cohen; Richard Dickinson
Weitere Kernanwält*innen
Brian Cordery; Robert Burrows; Alex Denoon; Xisca Borrás; Adrian Chew; Claire Smith; Matthew Warren; Robert Vidal